Update 1-Ardelyx bowel drug succeeds in mid-stage trial

October 1, 2014 12:56 PM

3 0

Oct 1 (Reuters) - Ardelyx Inc said its experimental drug to treat constipation-related irritable bowel syndrome achieved the main goal of increasing bowel movement compared with a placebo in a mid-stage study involving 371 patients.

The company's shares were up 5.6 percent at $15.00 in pre-market trading on the Nasdaq on Wednesday.

Also read: Harvard Reaches Goal of Cutting Gas Emissions by 30 Percent

Read more

To category page

Loading...